{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:36:20Z","timestamp":1775140580923,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2004,3,8]],"date-time":"2004-03-08T00:00:00Z","timestamp":1078704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,3,8]],"date-time":"2004-03-08T00:00:00Z","timestamp":1078704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2004,5,1]]},"DOI":"10.1038\/sj.bmt.1704455","type":"journal-article","created":{"date-parts":[[2004,3,8]],"date-time":"2004-03-08T10:09:36Z","timestamp":1078740576000},"page":"901-905","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Effect of prior chemotherapy on hematopoietic stem cell mobilization"],"prefix":"10.1038","volume":"33","author":[{"given":"C D","family":"Ford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Warenski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F B","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,3,8]]},"reference":[{"key":"BF1704455_CR1","first-page":"11","volume":"9","author":"D Kotasek","year":"1992","unstructured":"Kotasek D, Shepherd KM, Sage RE et al. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 1992; 9: 11\u201317.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704455_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/scd.1.1995.4.171","volume":"4","author":"C Chabannon","year":"1995","unstructured":"Chabannon C, Le Coroller AG, Faucher C et al. Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factor. J Hematother 1995; 4: 171\u2013179.","journal-title":"J Hematother"},{"key":"BF1704455_CR3","first-page":"1065","volume":"18","author":"G Koumakis","year":"1996","unstructured":"Koumakis G, Vassilomanolakis M, Hatzichristou H et al. Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD, CHE) in various malignancies. Bone Marrow Transplant 1996; 18: 1065\u20131072.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704455_CR4","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1182\/blood.V83.12.3787.3787","volume":"83","author":"R Haas","year":"1994","unstructured":"Haas R, M\u00f6hle R, Fr\u00fchauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787\u20133794.","journal-title":"Blood"},{"key":"BF1704455_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/(SICI)1098-1101(1996)11:1<23::AID-JCA5>3.0.CO;2-D","volume":"11","author":"YK Keung","year":"1996","unstructured":"Keung YK, Cobos E, Dunn D et al. Determining factors for the outcome of peripheral blood progenitor cells harvests. J Clin Apheresis 1996; 11: 23\u201326.","journal-title":"J Clin Apheresis"},{"key":"BF1704455_CR6","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1046\/j.1537-2995.1997.371098016444.x","volume":"37","author":"A Humpe","year":"1997","unstructured":"Humpe A, Riggert J, Vehmeyer K et al. Comparison of CD34+ cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapy. Transfusion 1997; 37: 1050\u20131057.","journal-title":"Transfusion"},{"key":"BF1704455_CR7","first-page":"273","volume":"14","author":"A Olivieri","year":"1994","unstructured":"Olivieri A, Offidani M, Ciniero L et al. Optimization of the yield of PBSC for autotransplantation mobilized by high-dose chemotherapy and G-CSF: proposal for a mathematical model. Bone Marrow Transplant 1994; 14: 273\u2013278.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704455_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2257.1991.tb00248.x","volume":"13","author":"KM Shepherd","year":"1991","unstructured":"Shepherd KM, Charles P, Sage RE et al. Mobilization of haemopoietic stem cells by cyclophosphamide into the peripheral blood of patients with haematological malignancies. Clin Lab Haematol 1991; 13: 25\u201332.","journal-title":"Clin Lab Haematol"},{"key":"BF1704455_CR9","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1200\/JCO.1995.13.10.2547","volume":"13","author":"W Bensinger","year":"1995","unstructured":"Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547\u20132555.","journal-title":"J Clin Oncol"},{"key":"BF1704455_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/096368979600500304","volume":"5","author":"K Imrie","year":"1996","unstructured":"Imrie K, Stewart K, Crump RM et al. Blood stem cell collection: factors influencing the recovery of granulocyte\u2013macrophage colony forming cells. Cell Transplant 1996; 5: 379\u2013383.","journal-title":"Cell Transplant"},{"key":"BF1704455_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1365-2141.1997.1812998.x","volume":"98","author":"IG McQuaker","year":"1997","unstructured":"McQuaker IG, Haynes AP, Stainer C et al. Stem cell mobilization in resistant or relapsed lymphoma. Superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol 1997; 98: 228\u2013233.","journal-title":"Br J Haematol"},{"key":"BF1704455_CR12","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1046\/j.1365-2141.1997.2783095.x","volume":"98","author":"H Goldschmidt","year":"1997","unstructured":"Goldschmidt H, Hegenbart U, Wallmeier M et al. Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma. Br J Haematol 1997; 98: 736\u2013744.","journal-title":"Br J Haematol"},{"key":"BF1704455_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0145-2126(96)00059-8","volume":"21","author":"J Morton","year":"1997","unstructured":"Morton J, Morton A, Bird R et al. Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSF. Leukemia Res 1997; 21: 21\u201327.","journal-title":"Leukemia Res"},{"key":"BF1704455_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1089\/scd.1.1996.5.213","volume":"5","author":"R Sutherland","year":"1996","unstructured":"Sutherland R, Anderson L, Keeney M et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996; 5: 213\u2013226.","journal-title":"J Hematother"},{"key":"BF1704455_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1046\/j.1537-2995.2003.00376.x","volume":"43","author":"CD Ford","year":"2003","unstructured":"Ford CD, Chan K, Reilly WF, Petersen FB . An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors. Transfusion 2003; 43: 622\u2013625.","journal-title":"Transfusion"},{"key":"BF1704455_CR16","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1046\/j.1537-2995.2002.00131.x","volume":"42","author":"CD Ford","year":"2002","unstructured":"Ford CD, Greenwood J, Strupp A, Lehman CM . Change in CD34+ cell concentration during peripheral blood stem cell collection: effects on collection efficiency and efficacy. Transfusion 2002; 42: 904\u2013911.","journal-title":"Transfusion"},{"key":"BF1704455_CR17","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1182\/blood.V98.7.2059","volume":"98","author":"U Narayanasami","year":"2001","unstructured":"Narayanasami U, Kanteti R, Morelli J et al. Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation. Blood 2001; 98: 2059\u20132064.","journal-title":"Blood"},{"key":"BF1704455_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1046\/j.1365-2141.1998.00573.x","volume":"100","author":"CH Weaver","year":"1998","unstructured":"Weaver CH, Birch R, Greco L et al. Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim. Br J Haematol 1998; 100: 338\u2013347.","journal-title":"Br J Haematol"},{"key":"BF1704455_CR19","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1046\/j.1365-2141.2002.03264.x","volume":"116","author":"T Demirer","year":"2002","unstructured":"Demirer T, Ayli M, Ozcan M et al. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF. Br J Haematol 2002; 116: 468\u2013474.","journal-title":"Br J Haematol"},{"key":"BF1704455_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1046\/j.1537-2995.2003.00273.x","volume":"43","author":"M Andre","year":"2003","unstructured":"Andre M, Baudoux E, Bron D et al. Phase III randomized study comparing 5 or 10\u2009g per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies. Transfusion 2003; 43: 50\u201357.","journal-title":"Transfusion"},{"key":"BF1704455_CR21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1046\/j.1365-2141.1997.2743091.x","volume":"98","author":"M Drake","year":"1997","unstructured":"Drake M, Ranaghan L, Morris TCM et al. Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system. Br J Haematol 1997; 98: 745\u2013749.","journal-title":"Br J Haematol"},{"key":"BF1704455_CR22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/sj.bmt.1701461","volume":"22","author":"RE Clark","year":"1998","unstructured":"Clark RE, Brammer CG . Previous treatment predicts the efficiency of blood progenitor cell mobilization: validation of a chemotherapy scoring system. Bone Marrow Transplant 1998; 22: 859\u2013863.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704455_CR23","first-page":"156","volume":"21","author":"S Neben","year":"1993","unstructured":"Neben S, Hemman S, Montgomery M et al. Hematopoietic stem cell deficit of transplanted bone marow previously exposed to cytotoxic agents. Exp Hematol 1993; 21: 156\u2013162.","journal-title":"Exp Hematol"},{"key":"BF1704455_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/BF00253055","volume":"18","author":"G Molineux","year":"1986","unstructured":"Molineux G, Xu C, Hendry J, Testa NG . A cellular analysis of long-term haematopoietic damage in mice after repeated treatment with cyclophosphamide. Cancer Chemother Pharmacol 1986; 18: 11\u201316.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1704455_CR25","first-page":"153","volume":"12","author":"SS Adler","year":"1984","unstructured":"Adler SS, Kuznetshy RD . Effects of chemotherapeutic agents on hemopoietic stromal tissue: I. Effects of cyclophosphamide and bleomycin on hemopoiesis in subcutaneous femur implants. Exp Hematol 1984; 12: 153\u2013161.","journal-title":"Exp Hematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704455","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:10:07Z","timestamp":1648077007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,8]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,5,1]]}},"alternative-id":["BF1704455"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704455","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,8]]},"assertion":[{"value":"2 October 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}